Rheumatic Heart Disease Patients’ Adherence to Secondary Prophylaxis and Associated Factors at Hospitals in Jimma Zone, Southwest Ethiopia: A Multicenter Study

References

• Carapetis JR, Beaton A, Cunningham MW, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers. 2016;2(1):1–24.
   Web of Science ®Google Scholar
• Zühlke LJ, Engel ME, Watkins D, Mayosi BM. Incidence, prevalence and outcome of rheumatic heart disease in South Africa: a systematic review of contemporary studies. Int J Cardiol. 2015;199:375–383.
   PubMed Web of Science ®Google Scholar
• Coffey PM, Ralph AP, Krause VL. The role of social determinants of health in the risk and prevention of group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: a systematic review. PLoS Negl Trop Dis. 2018;12(6):e0006577. doi:10.1371/journal.pntd.0006577
   PubMed Web of Science ®Google Scholar
• Nulu S, Bukhman G, Kwan GF. Rheumatic heart disease: the unfinished global agenda. Cardiol Clin. 2017;35(1):165–180. doi:10.1016/j.ccl.2016.08.006
   Web of Science ®Google Scholar
• Palafox B, Mocumbi AO, Kumar RK, et al. The WHF roadmap for reducing CV morbidity and mortality through prevention and control of RHD. Glob Heart. 2017;12(1):47–62. doi:10.1016/j.gheart.2016.12.001
   Web of Science ®Google Scholar
• Gemechu T, Mahmoud H, Parry EH, Phillips DI, Yacoub MH. Community-based prevalence study of rheumatic heart disease in rural Ethiopia. Eur J Prev Cardiol. 2017;24(7):717–723. doi:10.1177/2047487316687104
   PubMed Web of Science ®Google Scholar
• Dougherty S, Khorsandi M, Herbst P. Rheumatic heart disease screening: current concepts and challenges. Ann Pediatr Cardiol. 2017;10(1):39. doi:10.4103/0974-2069.197051
   Web of Science ®Google Scholar
• Steer AC, Kado J, Wilson N, et al. High prevalence of rheumatic heart disease by clinical and echocardiographic screening among children in Fiji. J Heart Valve Dis. 2009;18(3):327–335.
   Web of Science ®Google Scholar
• Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet. 2005;366(9480):155–168. doi:10.1016/S0140-6736(05)66874-2
   PubMed Web of Science ®Google Scholar
• Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685–694. doi:10.1016/S1473-3099(05)70267-X
   PubMed Web of Science ®Google Scholar
• Carapetis JR, Mayosi BM, Kaplan EL. Controlling rheumatic heart disease in developing countries. Cardiovasc J S Afr. 2006;17(4):164–165.
   Google Scholar
• Watkins DA, Johnson CO, Colquhoun SM, et al. Global, regional, and national burden of rheumatic heart disease, 1990–2015. N Engl J Med. 2017;377(8):713–722. doi:10.1056/NEJMoa1603693
   PubMed Web of Science ®Google Scholar
• Milne RJ, Lennon D, Stewart JM, Vander Hoorn S, Scuffham PA. Mortality and hospitalisation costs of rheumatic fever and rheumatic heart disease in New Zealand. J Paediatr Child Health. 2012;48(8):692–697. doi:10.1111/j.1440-1754.2012.02446.x
   PubMed Web of Science ®Google Scholar
• Cilliers AM. Rheumatic fever and its management. BMJ. 2006;333(7579):1153–1156. doi:10.1136/bmj.39031.420637.BE
   Web of Science ®Google Scholar
• Meira ZMA, Goulart EMA, Colosimo EA, Mota CCC. Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents. Heart. 2005;91(8):1019–1022. doi:10.1136/hrt.2004.042762
   Web of Science ®Google Scholar
• Feinstein AR, Stern EK, Spagnuolo M. The prognosis of acute rheumatic fever. Am Heart J. 1964;68(6):817–834. doi:10.1016/0002-8703(64)90132-2
   Web of Science ®Google Scholar
• Mayosi BM, Gamra H, Dangou J-M, Kasonde J. Rheumatic heart disease in Africa: the Mosi-o-Tunya call to action. Lancet Glob Health. 2014;2(8):e438–e439. doi:10.1016/S2214-109X(14)70234-7
   Web of Science ®Google Scholar
• Hewitson J, Zilla P. Children’s heart disease in sub-Saharan Africa: challenging the burden of disease: children’s heart disease. Sa Heart. 2010;7(1):18–29.
   Google Scholar
• Nkomo VT. Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa. Heart. 2007;93(12):1510–1519. doi:10.1136/hrt.2007.118810
   Web of Science ®Google Scholar
• Zühlke L, Mirabel M, Marijon E. Congenital heart disease and rheumatic heart disease in Africa: recent advances and current priorities. Heart. 2013;99(21):1554–1561.
   PubMed Web of Science ®Google Scholar
• Essop MR, Nkomo VT. Rheumatic and nonrheumatic valvular heart disease: epidemiology, management, and prevention in Africa. Circulation. 2005;112(23):3584–3591. doi:10.1161/CIRCULATIONAHA.105.539775
   Web of Science ®Google Scholar
• McLaren MJ, Markowitz M, Gerber MA. Rheumatic heart disease in developing countries: the consequence of inadequate prevention. Ann Intern Med. 1994;120(3):243–245. doi:10.7326/0003-4819-120-3-199402010-00012
   Web of Science ®Google Scholar
• Eisenberg MJ. Rheumatic heart disease in the developing world: prevalence, prevention, and control. Eur Heart J. 1993;14(1):122–128. doi:10.1093/eurheartj/14.1.122
   Web of Science ®Google Scholar
• Carapetis JR. Rheumatic heart disease in developing countries. N Engl J Med. 2007;357(5):439–441. doi:10.1056/NEJMp078039
   PubMed Web of Science ®Google Scholar
• Hodes RM. Pattern of heart disease in Ethiopia as seen in a cardiology referral clinic. Cardiology. 1988;75(6):458–464. doi:10.1159/000174417
   Web of Science ®Google Scholar
• Habte B, Alemseged F, Tesfaye D. The pattern of cardiac diseases at the cardiac clinic of Jimma University specialised hospital, south West Ethiopia. Ethiop J Health Sci. 2010;20(2).
   Google Scholar
• Oli K, Asmera J. Rheumatic heart disease in Ethiopia: could it be more malignant? Ethiop Med J. 2004;42(1):1–8.
   PubMedGoogle Scholar
• WHO. WHO programme for the prevention of rheumatic fever/rheumatic heart disease in 16 developing countries: report from Phase I (1986–90). WHO Cardiovascular Diseases Unit and principal investigators. Bull World Health Organ. 1992;70(2):213–218.
   Web of Science ®Google Scholar
• Mohammed K, Demissie WR, Gare MB. Adherence of rheumatic heart disease patients to secondary prophylaxis and main reasons for poor adherence at Jimma Medical Center. E J Cardiovasc Med. 2019;7(1):22. doi:10.32596/ejcm.galenos.2019.00004
   Google Scholar
• Reményi B, Wilson N, Steer A, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease—an evidence-based guideline. Nat Rev Cardiol. 2012;9(5):297–309.
   PubMed Web of Science ®Google Scholar
• Pelajo CF, Lopez-Benitez JM, Torres JM, de Oliveira SK. Adherence to secondary prophylaxis and disease recurrence in 536 Brazilian children with rheumatic fever. Pediatr Rheumatol. 2010;8(1):22. doi:10.1186/1546-0096-8-22
   Web of Science ®Google Scholar
• WHO. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization; 2003.
   Google Scholar
• Sabaté E, Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization; 2003.
   Google Scholar
• Harrington Z, Thomas DP, Currie BJ, Bulkanhawuy J. Challenging perceptions of non-compliance with rheumatic fever prophylaxis in a remote Aboriginal community. Med J Aust. 2006;184(10):514–517. doi:10.5694/j.1326-5377.2006.tb00347.x
   PubMed Web of Science ®Google Scholar
• Carapetis JR, Zühlke LJ. Global research priorities in rheumatic fever and rheumatic heart disease. Ann Pediatr Cardiol. 2011;4(1):4. doi:10.4103/0974-2069.79616
   PubMedGoogle Scholar
• Remenyi B, Carapetis J, Wyber R, Taubert K, Mayosi BM. Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol. 2013;10(5):284. doi:10.1038/nrcardio.2013.34
   PubMed Web of Science ®Google Scholar
• Mekonen KK, Yismaw MB, Abiye AA, Tadesse TA. Adherence to Benzathine Penicillin G secondary prophylaxis and its determinants in patients with rheumatic heart disease at a cardiac center of an Ethiopian Tertiary Care Teaching Hospital. Patient Prefer Adherence. 2020;14:343. doi:10.2147/PPA.S238423
   Web of Science ®Google Scholar
• Gasse B, Baroux N, Rouchon B, Meunier J-M, De Frémicourt I, D’Ortenzio E. Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study. BMC Public Health. 2013;13(1):131. doi:10.1186/1471-2458-13-131
   Web of Science ®Google Scholar
• Farzana K, Faruque MO, Zareen S, Choudhury KN, Hossain A. Factors affecting therapeutic compliance among the patients with rheumatic heart disease in Bangladesh. Cardiovasc J. 2018;10(2):180–185. doi:10.3329/cardio.v10i2.36289
   Google Scholar
• Janvier D Factors, beliefs and barriers associated with adherence to secondary prophylaxis amongst children and adolescents with rheumatic heart disease at Public Tertiary Hospitals in Rwanda–a cross-sectional study; 2019.
   Google Scholar
• Ralph AP, Read C, Johnston V, et al. Improving delivery of secondary prophylaxis for rheumatic heart disease in remote Indigenous communities: study protocol for a stepped-wedge randomised trial. Trials. 2016;17(1):51. doi:10.1186/s13063-016-1166-y
   Web of Science ®Google Scholar
• Nemani L, Maddury J, Barik R, Arigondam AK. A Cross-sectional study to look at the determinants of poor adherence to secondary penicillin prophylaxis for rheumatic heart disease at a tertiary care center in South India. J Clin Prev Cardiol. 2018;7(1):5. doi:10.4103/JCPC.JCPC_25_17
   Google Scholar
• Huck DM, Nalubwama H, Longenecker CT, Frank SH, Okello E, Webel AR. A qualitative examination of secondary prophylaxis in rheumatic heart disease: factors influencing adherence to secondary prophylaxis in Uganda. Glob Heart. 2015;10(1):63–69. doi:10.1016/j.gheart.2014.10.001
   PubMed Web of Science ®Google Scholar
• Sayed GA Compliance for secondary prophylaxis for controlling rheumatic fever and rheumatic heart disease in Egyptian children; 2011.
   Google Scholar
• Kumar R, Thakur JS, Aggarwal A, Ganguly NK. Compliance of secondary prophylaxis for controlling rheumatic fever and rheumatic heart disease in a rural area of northern India. Indian Heart J. 1997;49(3):282.
   Google Scholar
• Prasad A, Prasad A, Singh BK, Kumar S. Compliance to the secondary prophylaxis and awareness of rheumatic heart disease: a cross-sectional study in low-income province of India. J Fam Med Primary Care. 2020;9(3):1431. doi:10.4103/jfmpc.jfmpc_1056_19
   Google Scholar
• Gordis L, Markowitz M, Lilienfeld AM. Why patients don’t follow medical advice: a study of children on long-term antistreptococcal prophylaxis. J Pediatr. 1969;75(6):957–968. doi:10.1016/S0022-3476(69)80332-X
   Web of Science ®Google Scholar
• Thompson SB, Brown CH, Edwards AM, Lindo JLM. Low adherence to secondary prophylaxis among clients diagnosed with rheumatic fever, Jamaica. Pathog Glob Health. 2014;108(5):229–234. doi:10.1179/2047773214Y.0000000146
   PubMed Web of Science ®Google Scholar
• De Dassel JL, Fittock MT, Wilks SC, Poole JE, Carapetis JR, Ralph AP. Adherence to secondary prophylaxis for rheumatic heart disease is underestimated by register data. PLoS One. 2017;12(5):e0178264. doi:10.1371/journal.pone.0178264
   Web of Science ®Google Scholar
• Watkins D, Zuhlke L, Engel M, et al. Seven key actions to eradicate rheumatic heart disease in Africa: the Addis Ababa communiqué. Cardiovasc J Afr. 2016;27(3):184–187. doi:10.5830/CVJA-2015-090
   Web of Science ®Google Scholar
• WHO. Rheumatic fever and rheumatic heart disease. Available from: https://www.who.int/cardiovascular_diseases/publications/trs923/en/. Accessed November 1, 2020.
   Google Scholar
• Saxena A, Mehta A, Ramakrishnan S. Adherence to benzathine penicillin in children with rheumatic fever/rheumatic heart disease: results from an Indian pediatric RHD registry. J Am Coll Cardiol. 2015;65(10 Supplement):A2019. doi:10.1016/S0735-1097(15)62019-8
   Web of Science ®Google Scholar
• Musoke C, Mondo CK, Zhang W, et al. Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital. Cardiovasc J Afr. 2013;24(4):124. doi:10.5830/CVJA-2013-022
   PubMed Web of Science ®Google Scholar
• Culliford-Semmens N, Tilton E, Webb R, et al. Adequate adherence to benzathine penicillin secondary prophylaxis following the diagnosis of rheumatic heart disease by echocardiographic screening. N Z Med J. 2017;130(1457):50.
   PubMed Web of Science ®Google Scholar
• Sial JA, Farman MT, Batra MK, Karim M. Adherence to secondary prophylaxis of rheumatic fever in patients with rheumatic heart disease in rural areas. Pak Heart J. 2018;51(3).
   Web of Science ®Google Scholar
• Huck DM, Nalubwama H, Longenecker CT, et al. Examination of secondary prophylaxis in rheumatic heart disease: factors influencing adherence to secondary prophylaxis in Uganda. Glob Heart. 2015;10(1):63–69.e1. doi:10.1016/j.gheart.2014.10.001
   PubMed Web of Science ®Google Scholar
• Andrea B, Robert M, Craig S, Emmy O, Peter L, Charles M. Response to letters regarding article, “Echocardiography screening for rheumatic heart disease in Ugandan Schoolchildren”. Circulation. 2012;126(25):e478–e479. doi:10.1161/CIRCULATIONAHA.112.147538
   Web of Science ®Google Scholar
• Sanyahumbi A, Beaton A, Guffey D, et al. Two-year evolution of latent rheumatic heart disease in Malawi. Congenit Heart Dis. 2019;14(4):614–618. doi:10.1111/chd.12756
   Web of Science ®Google Scholar
• Pallangyo P, Millinga J, Bhalia S, et al. Medication adherence and survival among hospitalized heart failure patients in a tertiary hospital in Tanzania: a prospective cohort study. BMC Res Notes. 2020;13(1):89. doi:10.1186/s13104-020-04959-w
   PubMed Web of Science ®Google Scholar
• Prendergast AJ Perkins S, Joachim A. Participation in research improves overall patient management: insights from the Global Rheumatic Heart Disease registry (REMEDY). Cardiovasc J Afr. 2018;29(2):98–105. doi:10.5830/CVJA-2017-054
   Web of Science ®Google Scholar
• Petricca K, Mamo Y, Haileamlak A, Seid E, Parry E. Barriers to effective follow-up treatment for rheumatic heart disease in Jmma, Ethiopia: a grounded theory analysis of the patient experience. Ethiop J Health Sci. 2009;19(1).
   Google Scholar